Alkem Laboratories Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA2,1762,2160
EBIT1,9011,8970
Earning Per Share13213782
Expenses6,9238,5819,990
Net Profit1,6181,6801,007
Net Profit Margin18169
Operating Profit Margin252116
Profit Before Tax1,8421,8441,305
Dividends Per Share30340
Operation Revenue9,09810,79711,815

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Alkem Laboratories is 0 as of 9/24/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20152015201520152019
Operating Activities325325325325780
Investing Activities-237-237-237-237-316
Financing Activities-52-52-52-52-379
Others00000
Net Cash Flow3737373784

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Alkem Laboratories is 780 as of 9/24/2023